Cellebrite DI Ltd. (CLBT)
- Previous Close
10.71 - Open
10.77 - Bid 10.86 x 100
- Ask 10.92 x 100
- Day's Range
10.71 - 10.89 - 52 Week Range
5.22 - 12.50 - Volume
419,887 - Avg. Volume
944,819 - Market Cap (intraday)
2.234B - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.43 - Earnings Date Feb 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
13.58
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.
www.cellebrite.com1,008
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CLBT
Performance Overview: CLBT
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLBT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLBT
Valuation Measures
Market Cap
2.23B
Enterprise Value
1.94B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.36
Price/Book (mrq)
65.29
Enterprise Value/Revenue
5.98
Enterprise Value/EBITDA
-29.73
Financial Highlights
Profitability and Income Statement
Profit Margin
-26.03%
Return on Assets (ttm)
4.47%
Return on Equity (ttm)
-150.08%
Revenue (ttm)
311.55M
Net Income Avi to Common (ttm)
-81.1M
Diluted EPS (ttm)
-0.43
Balance Sheet and Cash Flow
Total Cash (mrq)
302.92M
Total Debt/Equity (mrq)
41.30%
Levered Free Cash Flow (ttm)
81.72M